Selected article for: "high expression and lymph node"

Title: RESEARCH COMMUNICATIONS OF THE 28th ECVIM-CA CONGRESS
  • Document date: 2018_12_19
  • ID: r79h9yzz_546
    Snippet: The high levels of TGFβ were associated with skin ulceration (p = 0.018), tumor necrosis (p = 0.024), high mitotic index (p < 0.001), marked nuclear pleomorphism (p = 0.001), poor tumor differentiation (p < 0.001), high histological grade of malignancy HGM (p < 0.001), presence of neoplastic intravascular emboli (p < 0.001) and presence of lymph node metastases (p < 0.001). The levels of TGFβ were positively correlated with intratumoral FoxP3 (.....
    Document: The high levels of TGFβ were associated with skin ulceration (p = 0.018), tumor necrosis (p = 0.024), high mitotic index (p < 0.001), marked nuclear pleomorphism (p = 0.001), poor tumor differentiation (p < 0.001), high histological grade of malignancy HGM (p < 0.001), presence of neoplastic intravascular emboli (p < 0.001) and presence of lymph node metastases (p < 0.001). The levels of TGFβ were positively correlated with intratumoral FoxP3 (r = 0.719; p < 0.001), VEGF (r = 0.378; p = 0.002) and CD31 (r = 0.511; p < 0.001). Tumors with concurrent high expression of TGFβ/FoxP3, TGFβ/VEGF and TGFβ/CD31 markers were associated with parameters of tumor malignancy (high HGM, presence of neoplastic vascular emboli and presence of lymph node metastasis). Additionally tumors with abundant TGFβ and with concurrent high expression of TGFβ/FoxP3, TGFβ/VEGF and TGFβ/CD31 were associated with shorter overall survival (OS) time (p < 0.001). Interestingly TGFβ/FoxP3 class retained the association with shorter OS in multivariate analysis, arising as independent predictor of poor prognosis (9.731 hazard ratio, p < 0.001).

    Search related documents:
    Co phrase search for related documents
    • hazard ratio and high level: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20
    • hazard ratio and histological grade: 1
    • hazard ratio and independent predictor: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • hazard ratio and lymph node metastasis: 1, 2, 3, 4, 5, 6
    • hazard ratio and lymph node metastasis presence: 1
    • hazard ratio and multivariate analysis: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • hazard ratio and node metastasis: 1, 2, 3, 4, 5, 6, 7
    • hazard ratio and os time: 1, 2, 3, 4, 5, 6
    • high expression and histological grade: 1, 2, 3, 4, 5
    • high expression and independent predictor: 1, 2, 3, 4
    • high expression and lymph node metastasis: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • high expression and lymph node metastasis presence: 1, 2
    • high expression and multivariate analysis: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20
    • high expression and node metastasis: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
    • high expression and os time: 1, 2, 3
    • high level and lymph node metastasis presence: 1
    • high level and multivariate analysis: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • high level and node metastasis: 1, 2, 3
    • high level and os time: 1